Do males or females of non-child bearing potential have to wait 30 days to start isotretinoin, answer questions each month, and use contraception for the iPLEDGE program?
No, once the male patient or female not of childbearing potential patient is registered, the prescriber can start the 30-day prescription window by going to the manage patients screen and confirming patient counseling. Male patients and female patients not of childbearing potential do not have to answer questions each month in the iPLEDGE system; only female patients of child bearing potential need to do so. Males and females not of childbearing potential do not need to use contraception to qualify for the iPLEDGE program. • Can pregnancy tests be conducted prior to the prescriber office visit? Yes, the pregnancy test can be done prior to the prescriber office visit. For female patients of childbearing potential, the initial screening pregnancy test (1st test) must be conducted on the date of registration or no more than 30 days prior to patient registration. For ongoing monthly pregnancy tests, the specimen must be collected and processed in a CLIA certified laboratory and the date of
Related Questions
- Do males or females of non-child bearing potential have to wait 30 days to start isotretinoin, answer questions each month, and use contraception for the iPLEDGE program?
- Does a new female patient of childbearing potential (FCBP) starting on isotretinoin need to wait 30 days to start the medication if she is already taking birth control?
- How does the elimination of the 23-day lockout for Males and Females of Non-Childbearing Potential affect pharmacy requirements to obtain prescription authorizations?
